2-hexyl-4-pentynoic acid has been researched along with hydroxyurea in 2 studies
| Studies (2-hexyl-4-pentynoic acid) | Trials (2-hexyl-4-pentynoic acid) | Recent Studies (post-2010) (2-hexyl-4-pentynoic acid) | Studies (hydroxyurea) | Trials (hydroxyurea) | Recent Studies (post-2010) (hydroxyurea) |
|---|---|---|---|---|---|
| 5 | 0 | 4 | 8,969 | 741 | 2,156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Ding, W; Feng, Z; Lim, D; Liu, G; Wang, Z; Zhang, F | 1 |
| Cai, Z; Ding, C; Ding, W; Feng, Z; Li, Q; Lim, D; Liu, G; Su, B; Zhang, F | 1 |
2 other study(ies) available for 2-hexyl-4-pentynoic acid and hydroxyurea
| Article | Year |
|---|---|
2-hexyl-4-pentynoic acid, a potential therapeutic for breast carcinoma by influencing RPA2 hyperphosphorylation-mediated DNA repair.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA, Neoplasm; Fatty Acids, Unsaturated; Female; Humans; Hydroxyurea; MCF-7 Cells; Phosphorylation; Protein Processing, Post-Translational; Rad51 Recombinase; Recombinational DNA Repair; Replication Protein A | 2020 |
Histone deacetylase inhibitor 2-hexyl-4-pentynoic acid enhances hydroxyurea therapeutic effect in triple-negative breast cancer cells.
Topics: Cell Cycle; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; Drug Synergism; Fatty Acids, Unsaturated; Histone Deacetylase Inhibitors; Humans; Hydroxyurea; Triple Negative Breast Neoplasms | 2022 |